Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Haddad N, Delyon J, Trabelsi Messai S, Herms F, et al. Clinical response to immune checkpoint inhibition in patients with advanced skin cancers receiving concurrent ruxolitinib therapy for haematological malignancy. Br J Dermatol 2021;184:564-566.
PMID: 33058221


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016